blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1954830

EP1954830 - METHODS AND KITS FOR BREAST CANCER PROGNOSIS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.08.2012
Database last updated on 29.10.2024
Most recent event   Tooltip03.11.2017Change - lapse in a contracting statepublished on 06.12.2017  [2017/49]
Applicant(s)For all designated states
Sividon Diagnostics GmbH
Nattermann Allee 1
50829 Köln / DE
[2011/23]
Former [2009/01]For all designated states
Siemens Healthcare Diagnostics GmbH
Ludwig-Erhard-Strasse 12
65760 Eschborn / DE
Former [2008/33]For all designated states
Siemens Medical Solutions Diagnostics GmbH
Karl-Heinz-Kaske-Strasse 2
91052 Erlangen / DE
Inventor(s)01 / GEHRMANN, Mathias
Alte Landstr. 140
51373 Leverkusen / DE
02 / VON TOERNE, Christian
Höhrath 118
42659 Solingen / DE
 [2008/33]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2011/43]von Kreisler Selting Werner
Patentanwälte Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln / DE
Former [2011/23]von Kreisler Selting Werner
Patentanwälte Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln / DE
Former [2008/41]Maier, Daniel Oliver
Siemens AG Postfach 22 16 34
80506 München / DE
Former [2008/33]Maier, Daniel Oliver
Siemens Aktiengesellschaft Postfach 22 16 34
80506 München / DE
Application number, filing date06829113.723.11.2006
[2008/33]
WO2006EP11230
Priority number, dateEP2005002642303.12.2005         Original published format: EP 05026423
[2008/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007062777
Date:07.06.2007
Language:EN
[2007/23]
Type: A1 Application with search report 
No.:EP1954830
Date:13.08.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 07.06.2007 takes the place of the publication of the European patent application.
[2008/33]
Type: B1 Patent specification 
No.:EP1954830
Date:26.10.2011
Language:EN
[2011/43]
Search report(s)International search report - published on:EP07.06.2007
ClassificationIPC:C12Q1/68, G01N33/574, G01N33/68
[2008/33]
CPC:
G01N33/57415 (EP,US); C12Q1/6886 (EP,US); C12Q2600/112 (EP,US);
C12Q2600/118 (EP,US); G01N2333/91215 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/33]
TitleGerman:VERFAHREN UND KITS ZUR BRUSTKREBSPROGNOSE[2008/33]
English:METHODS AND KITS FOR BREAST CANCER PROGNOSIS[2008/33]
French:PROCEDES ET TROUSSES POUR LE PRONOSTIC DU CANCER DU SEIN[2008/33]
Entry into regional phase18.06.2008National basic fee paid 
18.06.2008Designation fee(s) paid 
18.06.2008Examination fee paid 
Examination procedure18.06.2008Examination requested  [2008/33]
03.09.2008Despatch of a communication from the examining division (Time limit: M06)
12.03.2009Reply to a communication from the examining division
16.11.2009Despatch of a communication from the examining division (Time limit: M06)
19.05.2010Reply to a communication from the examining division
18.07.2011Communication of intention to grant the patent
14.09.2011Fee for grant paid
14.09.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.09.2008
Opposition(s)27.07.2012No opposition filed within time limit [2012/40]
Fees paidRenewal fee
25.11.2008Renewal fee patent year 03
20.11.2009Renewal fee patent year 04
22.11.2010Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.10.2011
BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
HU26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
TR26.10.2011
IE23.11.2011
LU23.11.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
[2017/49]
Former [2014/03]AT26.10.2011
BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
HU26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
TR26.10.2011
IE23.11.2011
LU23.11.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2013/45]AT26.10.2011
BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
HU26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
TR26.10.2011
IE23.11.2011
IT23.11.2011
LU23.11.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2013/44]AT26.10.2011
BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
TR26.10.2011
IE23.11.2011
IT23.11.2011
LU23.11.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2013/29]AT26.10.2011
BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
IE23.11.2011
IT23.11.2011
LU23.11.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2013/25]AT26.10.2011
BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
IE23.11.2011
IT23.11.2011
LU23.11.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2013/07]AT26.10.2011
BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
IE23.11.2011
IT23.11.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/47]BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
IE23.11.2011
IT23.11.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/37]BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
IT23.11.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/36]BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
RO26.10.2011
SE26.10.2011
SI26.10.2011
SK26.10.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/35]BE26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
SE26.10.2011
SI26.10.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
BG26.01.2012
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/34]BE26.10.2011
CY26.10.2011
CZ26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
SE26.10.2011
SI26.10.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/33]BE26.10.2011
CY26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
SE26.10.2011
SI26.10.2011
CH30.11.2011
LI30.11.2011
MC30.11.2011
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/29]BE26.10.2011
CY26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
SE26.10.2011
SI26.10.2011
MC30.11.2011
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/28]BE26.10.2011
CY26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
SE26.10.2011
SI26.10.2011
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/24]BE26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
SE26.10.2011
SI26.10.2011
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/23]BE26.10.2011
LT26.10.2011
NL26.10.2011
GR27.01.2012
IS26.02.2012
PT27.02.2012
Former [2012/21]BE26.10.2011
LT26.10.2011
IS26.02.2012
Former [2012/20]LT26.10.2011
Cited inInternational search[XY]  - DISIS M L ET AL, "High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer.", JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY NOV 1997, (199711), vol. 15, no. 11, ISSN 0732-183X, pages 3363 - 3367, XP008075953 [X] 1-9,12,13,15,17,18,20,21 * abstract * * page 3364, column R * * page 3365 - page 3367 * [Y] 10,11,14
 [X]  - MENARD S ET AL, "ROLE OF HER2 GENE OVEREXPRESSION IN BREAST CARCINOMA", JOURNAL OF CELLULAR PHYSIOLOGY, LISS, NEW YORK, NY, US, (200002), vol. 182, no. 2, ISSN 0021-9541, pages 150 - 162, XP009012973 [X] 1-9,12,13,15,17,18,20,21 * abstract * * page 152 * * page 156 - page 157 *

DOI:   http://dx.doi.org/10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E
 [Y]  - PEROU C M ET AL, "Molecular portraits of human breast tumours", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, (20000817), vol. 406, no. 6797, ISSN 0028-0836, pages 747 - 752, XP002235791 [Y] 10,11,14 * abstract *

DOI:   http://dx.doi.org/10.1038/35021093
 [DA]  - WANG ET AL, "Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer", LANCET THE, LANCET LIMITED. LONDON, GB, (20050219), vol. 365, no. 9460, ISSN 0140-6736, pages 671 - 679, XP005081323 [DA] 1 * the whole document *
Examination   - VAN 'T VEER LAURA J ET AL, "Gene expression profiling predicts clinical outcome of breast cancer.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (20020131), Database accession no. NLM11823860
    - NATURE 31 JAN 2002, (20020131), vol. 415, no. 6871, ISSN 0028-0836, pages 530 - 536
    - ITO T ET AL, "Class distribution of immunoglobulin-containing plasma cells in the stroma of medullary carcinoma of breast.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (1986), Database accession no. NLM3013350
    - BREAST CANCER RESEARCH AND TREATMENT 1986, (1986), vol. 7, no. 2, ISSN 0167-6806, pages 97 - 103
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.